The NMC advertising guidelines, in your questions

The Guidelines shall come into force with immediate effect.

1.2 They shall come into force on the date of their publication by the National Medical Commission.

3.7 “Registered Medical Practitioners” or “RMP(s)” shall mean and include the Medical Practitioners registered under the NMC Act and whose names are either entered in the National Register under section 31 of the NMC Act or in the concerned State Medical Register.

4.1 These Guidelines shall apply to the professional conduct of the RMPs in relation to advertising, publicity, digital communication and promotional activities and to address the gap created due to advent of electronic media. These Guidelines are sought to be more comprehensive, specific and aligned to the needs of the present-day society.

4.2 In relation to RMPs, these Guidelines shall be read with the IMC (Professional Conduct, Etiquette and Ethics) Regulations, 2002, as amended from time to time, and the NMC Act, 2019. In case of any irreconcilable conflict, the applicable statutory provisions and operative regulations shall prevail.

The National Medical Commission may issue such clarifications, advisories, standard operating procedures or procedural instructions, consistent with these Guidelines and the National Medical Commission Act, 2019, as may be necessary for their effective and uniform implementation.

3.2 "Advertisement” mean any form of communication, promotion, publicity, announcement, representation or dissemination of information in any medium, which directly or indirectly solicits, promotes or is intended to promote the professional services, reputation, skills, qualifications, achievements, facilities or commercial healthcare services of an RMP or hospital/medical institution.

For the purposes of these Guidelines, digital, social-media, sponsored, targeted, influencer-led, search-engine, platform-based, audio-visual, AI-generated or AI-assisted promotional communications shall be treated as advertising where their content or manner of dissemination has a promotional character.

Explanation I - The discourse of information in the normal course of discharge of information to the public at large, without same being promotional and without any intent for commercial benefit shall be exempted from the above definition of “Advertisement”.

3.5 “Medium of advertisement” means and includes but is not limited to print media, Television, Radio, Social media platforms, websites and blogs, messaging platforms (WhatsApp, Telegrams, Facebook etc.),Podcasts, Influencer marketing, Digital marketing campaigns, sponsored posts, artificial intelligence generated promotion, public interviews, news articles intended for promotion, online healthcare platforms, any audio-visual or digital communication by whatsoever name called.

10.1 In case of violation of the above guidelines, actions will be taken by the concerned SMC against the erring RMP in accordance with the provisions ofthe NMC Act and Regulations made thereunder.The following graded action may be contemplated by the SMC concerned;

i. First Violation: Warning and mandatory ethics training.

ii. Second Violation: Censure and monetary penalty.

iii. Third Violation: Suspension of registration (3-6 months).

iv. Serious Violation (Misleading cure claims, inducement for patients, digital mass solicitation, etc.) Suspension of 6-12 months.

v. Repeated Violations: Removal from medical register for 1-3 years.

Any violation of these Guidelines by an RMP may, where applicable, constitute professional or ethical misconduct and shall be dealt with by the competent authority in accordance with the NMC Act, 2019, the applicable Ethics Regulations and the principles of natural justice.

The competent authority may, where legally permissible, impose such disciplinary or corrective measures, including censure, direction for corrective compliance/ethics sensitization, restriction or suspension of registration, removal from the register for a specified period or otherwise, and monetary penalty, as may be authorized under the NMC Act and applicable Regulations.

10.2 The penalties shall be imposed only after issuing a show-cause notice to the defaulting RMP and providing an opportunity to explain or clarify the alleged violation, in accordance with the applicable laws.

10.3 Where an RMP is found to be in violation of these Guidelines, the SMC shall issue a reasoned and speaking order setting out:

i. the specific violation identified;

ii. the contentions of the defaulting RMP/ and reasons for acceptance / rejection of the same;

iii. the reasons and basis for imposing the penalties.

11.1 Any RMP aggrieved by the findings or decision of the SMC may prefer an appeal before the Appellate Authority i.e, EMRB,NMC, within 60 days under Section 30 (3) of NMC Act, 2019.

11.2 The Appellate Authority shall independently examine the appeal and may, where considered necessary, call for the records and direct a fresh assessment, seek additional opinion, or undertake such further examination as it deems fit in accordance with these Guidelines.

11.3 The Appellate Authority shall pass a reasoned and speaking order, clearlyrecording the basis for affirming, modifying, or setting aside the findings of the SMC.

11.4 The decision on the first appeal may be contested by the RMP through second appeal, in accordance with Section 30 (4), NMC Act, 2019, within sixty days of communication of such decision.

Explanation V- No RMP or hospital/medical institution shall solicit, purchase, procure, manipulate or cause to be published fake, paid or misleading patient reviews, ratings, testimonials, endorsements or recommendations for the promotion of medical services. An RMP shall not request or share patient testimonials, recommendations, endorsements or reviews for professional promotion on social media.

3.6 “Social Media” shall mean and include all forms of publications and sharing through internet-based websites, apps, etc. by whatsoever name called, which allows users to create, share and join online communities, participate in social networking, etc.

6.2 Patient consent shall not, by itself, make permissible any testimonial, endorsement, promotional patient story, before-and-after depiction, success claim or other advertising practice that is otherwise prohibited under these Guidelines or applicable law.

v. Shall not publish cases for promotional purposes, advertise surgical results, display “before and after” photographs, publicize celebrity patients, promote personal success stories unless published strictly for scientific or educational purposes with anonymized patient consent.

i. Only research-based communication, wherein they have published interesting case studies in reputed medical journals shall be allowed.

Explanation V- No RMP or hospital/medical institution shall solicit, purchase, procure, manipulate or cause to be published fake, paid or misleading patient reviews, ratings, testimonials, endorsements or recommendations for the promotion of medical services. An RMP shall not request or share patient testimonials, recommendations, endorsements or reviews for professional promotion on social media.

xi. No RMP shall use or permit any celebrity, influencer, patient, employee or third party to promote professional services through prohibited testimonials, endorsements or recommendations. Any material commercial relationship in lawful public-health or informational communication shall be transparently disclosed in accordance with applicable law. No RMP or hospital/medical institution shall use a third party as an intermediary to do indirectly what the RMP or institution is prohibited from doing directly.

6.2 Patient consent shall not, by itself, make permissible any testimonial, endorsement, promotional patient story, before-and-after depiction, success claim or other advertising practice that is otherwise prohibited under these Guidelines or applicable law.

v. Shall not publish cases for promotional purposes, advertise surgical results, display “before and after” photographs, publicize celebrity patients, promote personal success stories unless published strictly for scientific or educational purposes with anonymized patient consent.

i. Only research-based communication, wherein they have published interesting case studies in reputed medical journals shall be allowed.

iii. Shall not advertise either personal achievements or professional success rates or number of patients treated with illustrative assertions such as

or any other unverifiable or exaggerated claims by whatsoever name called.

ix. No RMP or hospital/medical institution shall make comparative claims such as

or similar superiority claims unless the claim is objectively verifiable, based on a transparent and independently ascertainable methodology and is otherwise permissible under applicable law.

Provided, Any ranking or award relied upon in advertising shall be capable of independent verification, and material conditions, methodology and relevant date, details of award giving organization or firm shall be disclosed where necessary to avoid misleading the public.

ix. No RMP or hospital/medical institution shall make comparative claims such as

or similar superiority claims unless the claim is objectively verifiable, based on a transparent and independently ascertainable methodology and is otherwise permissible under applicable law.

Provided, Any ranking or award relied upon in advertising shall be capable of independent verification, and material conditions, methodology and relevant date, details of award giving organization or firm shall be disclosed where necessary to avoid misleading the public.

iii. Shall not advertise either personal achievements or professional success rates or number of patients treated with illustrative assertions such as

or any other unverifiable or exaggerated claims by whatsoever name called.

vi. Shall not publish any statement that creates unrealistic expectations, misrepresents treatment outcomes, conceals risks, promote unproven therapies, secret remedy or treatment whose composition, scientific basis, safety or efficacy is not adequately established or which is otherwise prohibited under applicable law.

iii. Shall not advertise either personal achievements or professional success rates or number of patients treated with illustrative assertions such as

or any other unverifiable or exaggerated claims by whatsoever name called.

vi. Shall not publish any statement that creates unrealistic expectations, misrepresents treatment outcomes, conceals risks, promote unproven therapies, secret remedy or treatment whose composition, scientific basis, safety or efficacy is not adequately established or which is otherwise prohibited under applicable law.

iv. Serious Violation (Misleading cure claims, inducement for patients, digital mass solicitation, etc.) Suspension of 6-12 months.

iii. Shall not advertise either personal achievements or professional success rates or number of patients treated with illustrative assertions such as

or any other unverifiable or exaggerated claims by whatsoever name called.

i. Only research-based communication, wherein they have published interesting case studies in reputed medical journals shall be allowed.

5.1 Medical Practitioners may participate in health awareness programmers, public health campaigns, academic discussions, educational content, provided that such activities do not promote personal practice, do not solicit patients and are not monetized through promotional marketing.

x. No RMP or hospital/medical institution shall use discounts, limited-period offers, contests, coupons, gifts, cashbacks, referral benefits, free procedures or similar inducements in a manner that is likely to encourage unnecessary medical consultation, diagnostic investigation or treatment or otherwise amounts to solicitation of patients.

Any lawful disclosure of charges, packages or fees shall be factual, transparent and not misleading.

iv. Serious Violation (Misleading cure claims, inducement for patients, digital mass solicitation, etc.) Suspension of 6-12 months.

7.2 AI Generated promotional campaign for furtherance of commercial interest is prohibited.Any AI generated promotional contentconforming to the provisions of these guidelines, the Regulations, and applicable Clinical Establishment Act and rules framed thereunder/ any other State Act as applicable, shall compulsorily carry the source mark, explicitly stating that the origin of the content is AI.

a) AI-generated or AI-assisted content shall not be used by an RMP or hospital/medical institution to create or disseminate misleading, deceptive or unverifiable representations concerning diagnosis, treatment, clinical outcomes, professional qualifications, patient experiences or healthcare services.

c) Where AI-generated or materially AI-altered content is used in a manner in which its artificial nature may reasonably be material to the audience's understanding of the communication, appropriate disclosure shall be made.

b) AI shall not be used to create or manipulate a patient's image, testimonial, voice or clinical outcome, or to create a synthetic endorsement or representation purporting to be that of an actual patient, RMP or other person.

Explanation III- RMP while publishing any Electronic media posts should transparently disclose their name, qualifications, registration status and SMR/NMR Registration number.

5.1 Medical Practitioners may participate in health awareness programmers, public health campaigns, academic discussions, educational content, provided that such activities do not promote personal practice, do not solicit patients and are not monetized through promotional marketing.

7.3 The prohibited practices relating to advertising, publicity, solicitation, endorsements, testimonials, patient images, misleading claims and digital manipulation shall be governed by Chapter III of these Guidelines. RMPs and clinical establishments shall also comply with the specific requirements relating to patient privacy, digital communication and AI contained in pre-paras of this Chapter.

Explanation - All campaigns on programmes/schemes of Government of India and the state Governments, which arein larger public interest, shall be exempted from these guidelines.

iii. Shall not advertise either personal achievements or professional success rates or number of patients treated with illustrative assertions such as

or any other unverifiable or exaggerated claims by whatsoever name called.

5.1 Medical Practitioners may participate in health awareness programmers, public health campaigns, academic discussions, educational content, provided that such activities do not promote personal practice, do not solicit patients and are not monetized through promotional marketing.

i. Shall not engage in advertisement/ activities intended to create unnecessary demand for medical procedures, promote unnecessary diagnostics and promote fear-based marketing.

iii. Medical Practitioners may deliver lectures or talks on public health and diseases for public awareness through television, radio and electronic media in their own name and designation, without promoting their employer organization.

3.5 “Medium of advertisement” means and includes but is not limited to print media, Television, Radio, Social media platforms, websites and blogs, messaging platforms (WhatsApp, Telegrams, Facebook etc.),Podcasts, Influencer marketing, Digital marketing campaigns, sponsored posts, artificial intelligence generated promotion, public interviews, news articles intended for promotion, online healthcare platforms, any audio-visual or digital communication by whatsoever name called.

7.1 RMP/ Clinical Establishments should use the social media in the most responsible manner and with the sole intention to balance public dissemination of information with utmost enforcement of patient integrity along with stringent adherence to professional ethics.

ii. A medical practitioner is however permitted to make a formal announcement regarding the following :

a) On starting practice.

b) On change of type of practice.

c) On changing address.

d) On temporary absence from duty.

e) On resumption of another practice.

f) On succeeding to another practice.

g) Public declaration of charge.

iv. Serious Violation (Misleading cure claims, inducement for patients, digital mass solicitation, etc.) Suspension of 6-12 months.

x. No RMP or hospital/medical institution shall use discounts, limited-period offers, contests, coupons, gifts, cashbacks, referral benefits, free procedures or similar inducements in a manner that is likely to encourage unnecessary medical consultation, diagnostic investigation or treatment or otherwise amounts to solicitation of patients.

Any lawful disclosure of charges, packages or fees shall be factual, transparent and not misleading.

v. Greeting on days of national importance or related to medical profession, etc. of National Day, etc. can be given by Medical Practitioners, however same should not contain advertisement of a professional gains.

iv. Serious Violation (Misleading cure claims, inducement for patients, digital mass solicitation, etc.) Suspension of 6-12 months.

ii. Shall not solicit patients directly or indirectly, promote his/her professional services through self-promotion, engage any third party for marketing medical services, permit the use of their name, image, voice, testimonial or endorsement for promotion of services or any products, participate in promotional campaigns giving an impression of commercialization of medical practice.

viii. The engagement of advertising agencies, digital marketing agencies, influencers or online platforms shall not be structured in a manner that results in payment or consideration being linked to the procurement or referral of individual patients.

xi. No RMP shall use or permit any celebrity, influencer, patient, employee or third party to promote professional services through prohibited testimonials, endorsements or recommendations. Any material commercial relationship in lawful public-health or informational communication shall be transparently disclosed in accordance with applicable law. No RMP or hospital/medical institution shall use a third party as an intermediary to do indirectly what the RMP or institution is prohibited from doing directly.

4.4 The fact that an advertisement or promotional communication is published through a digital platform, third party, advertising agency, influencer or other intermediary shall not, by itself, absolve an RMP or medical institution from responsibility for content which it has authorized, commissioned, sponsored, adopted or knowingly permitted. The disciplinary or statutory consequences shall, however, be determined by the competent authority under the applicable law.

11.5 In case of any violation by a hospital or medical institution, the corresponding penalty and appellate mechanism, in accordance with the Clinical Establishments Act and the Rules framed thereunder/ any other State Act as applicable, shall apply. Where an RMP has personally authorized, participated in, endorsed or otherwise been responsible for the prohibited communication, the professional conduct of such RMP may separately be examined by the concerned State Medical Council, Ethics and Medical Registration Board or National Medical Commission, as applicable.

For the purposes of these Guidelines, digital, social-media, sponsored, targeted, influencer-led, search-engine, platform-based, audio-visual, AI-generated or AI-assisted promotional communications shall be treated as advertising where their content or manner of dissemination has a promotional character.

xii. No RMP or hospital/medical institution shall procure, manipulate or cause any third party to procure or manipulate fake followers, likes, reviews, ratings, testimonials, comments, views or other digital engagement, or manipulate search rankings, visibility or algorithms to create a misleading impression of professional standing.

For the purposes of these Guidelines, digital, social-media, sponsored, targeted, influencer-led, search-engine, platform-based, audio-visual, AI-generated or AI-assisted promotional communications shall be treated as advertising where their content or manner of dissemination has a promotional character.

3.5 “Medium of advertisement” means and includes but is not limited to print media, Television, Radio, Social media platforms, websites and blogs, messaging platforms (WhatsApp, Telegrams, Facebook etc.),Podcasts, Influencer marketing, Digital marketing campaigns, sponsored posts, artificial intelligence generated promotion, public interviews, news articles intended for promotion, online healthcare platforms, any audio-visual or digital communication by whatsoever name called.

ii. Shall not solicit patients directly or indirectly, promote his/her professional services through self-promotion, engage any third party for marketing medical services, permit the use of their name, image, voice, testimonial or endorsement for promotion of services or any products, participate in promotional campaigns giving an impression of commercialization of medical practice.

Explanation V- No RMP or hospital/medical institution shall solicit, purchase, procure, manipulate or cause to be published fake, paid or misleading patient reviews, ratings, testimonials, endorsements or recommendations for the promotion of medical services. An RMP shall not request or share patient testimonials, recommendations, endorsements or reviews for professional promotion on social media.

xii. No RMP or hospital/medical institution shall procure, manipulate or cause any third party to procure or manipulate fake followers, likes, reviews, ratings, testimonials, comments, views or other digital engagement, or manipulate search rankings, visibility or algorithms to create a misleading impression of professional standing.

vii. No RMP shall, directly or indirectly, offer, pay, solicit, receive or participate in any commission, rebate, bonus, gift, gratuity, referral fee, lead-generation fee or other consideration in relation to the promotion or advertisement of medical services, where such consideration is connected with the referral, recommendation or procurement of patients, specimens or materials for diagnosis, treatment, surgery or other medical services.

iii. Shall not advertise either personal achievements or professional success rates or number of patients treated with illustrative assertions such as

or any other unverifiable or exaggerated claims by whatsoever name called.

iii. Shall not advertise either personal achievements or professional success rates or number of patients treated with illustrative assertions such as

or any other unverifiable or exaggerated claims by whatsoever name called.

ix. No RMP or hospital/medical institution shall make comparative claims such as

or similar superiority claims unless the claim is objectively verifiable, based on a transparent and independently ascertainable methodology and is otherwise permissible under applicable law.

Provided, Any ranking or award relied upon in advertising shall be capable of independent verification, and material conditions, methodology and relevant date, details of award giving organization or firm shall be disclosed where necessary to avoid misleading the public.

ix. No RMP or hospital/medical institution shall make comparative claims such as

or similar superiority claims unless the claim is objectively verifiable, based on a transparent and independently ascertainable methodology and is otherwise permissible under applicable law.

Provided, Any ranking or award relied upon in advertising shall be capable of independent verification, and material conditions, methodology and relevant date, details of award giving organization or firm shall be disclosed where necessary to avoid misleading the public.

Explanation II- Information regarding availability or installation of equipment, technology, diagnostic facilities or services may be disseminated as factual information, provided that such communication does not contain claims of superiority, guaranteed accuracy, guaranteed outcomes, comparative claims or other misleading or unverifiable representations.

9.2 Use of the photograph/image of an RMP shall not be permitted; where such use constitutes self-advertisement, solicitation or promotional publicity. In particular, use of self-photograph or similar publicity material on the letterhead or signboard of a consulting room or clinical establishment shall be governed by Regulations 6.1.1 and 6.1.2 of the Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002, and regarded as unethical conduct.

6.1 Patient information, photographs, videos, medical records, clinical images, treatment details, testimonials or other identifiable information shall not be used for advertising purposes except where such use is permitted by applicable law and the necessary consent and other safeguards have been duly complied with.

6.3 Where consent is legally required, it shall be specific, informed, voluntary, documented and capable of verification, and shall comply with applicable privacy and data-protection law. The form and mode of recording consent shall be determined in accordance with the applicable law and the nature and purpose of the proposed use.

6.4 Even where disclosure is lawfully permitted, reasonable safeguards shall be adopted by the hospital/medical institution and RMP shall be duty bound to prevent unnecessary disclosure of names or to crop, blur, black out, birth marks/ identification marks, or other information through which the patient may be identified.

7.4 RMP/ Clinical establishment shall not share any patient data, such as names, faces, anomalies, etc., which can be identified publicly.

v. Shall not publish cases for promotional purposes, advertise surgical results, display “before and after” photographs, publicize celebrity patients, promote personal success stories unless published strictly for scientific or educational purposes with anonymized patient consent.

7.5 Nothing in these Guidelines shall be construed as permitting the live broadcast or commercial dissemination of surgical or clinical procedures in a manner inconsistent with the applicable NMC guidelines, directions or advisories relating to live surgery broadcasts.

Any live surgery broadcast shall comply with the applicable NMC framework governing patient safety, consent, privacy, educational purpose, sponsorship, commercialization and professional conduct.

x. No RMP or hospital/medical institution shall use discounts, limited-period offers, contests, coupons, gifts, cashbacks, referral benefits, free procedures or similar inducements in a manner that is likely to encourage unnecessary medical consultation, diagnostic investigation or treatment or otherwise amounts to solicitation of patients.

Any lawful disclosure of charges, packages or fees shall be factual, transparent and not misleading.

ii. A medical practitioner is however permitted to make a formal announcement regarding the following :

a) On starting practice.

b) On change of type of practice.

c) On changing address.

d) On temporary absence from duty.

e) On resumption of another practice.

f) On succeeding to another practice.

g) Public declaration of charge.

9.3 RMP can issue a formal announcement which are factual, non-promotional and limited in scope regarding starting of practice, change of address, change of practice type, temporary absence, resumption of practice, public declaration of consultation fees.

3.5 “Medium of advertisement” means and includes but is not limited to print media, Television, Radio, Social media platforms, websites and blogs, messaging platforms (WhatsApp, Telegrams, Facebook etc.),Podcasts, Influencer marketing, Digital marketing campaigns, sponsored posts, artificial intelligence generated promotion, public interviews, news articles intended for promotion, online healthcare platforms, any audio-visual or digital communication by whatsoever name called.

iii. Shall not advertise either personal achievements or professional success rates or number of patients treated with illustrative assertions such as

or any other unverifiable or exaggerated claims by whatsoever name called.

iv. An RMP shall not give, directly or indirectly, any approval, recommendation, endorsement, certificate, report or statement concerning any drug, medicine, remedy, therapeutic article, apparatus, appliance, medical device, diagnostic product, health product or commercial product for use in advertising or publicity in connection with his/her name, signature, photograph, voice or professional status, whether or not monetary or other consideration is received.

xi. No RMP shall use or permit any celebrity, influencer, patient, employee or third party to promote professional services through prohibited testimonials, endorsements or recommendations. Any material commercial relationship in lawful public-health or informational communication shall be transparently disclosed in accordance with applicable law. No RMP or hospital/medical institution shall use a third party as an intermediary to do indirectly what the RMP or institution is prohibited from doing directly.

ii. Shall not solicit patients directly or indirectly, promote his/her professional services through self-promotion, engage any third party for marketing medical services, permit the use of their name, image, voice, testimonial or endorsement for promotion of services or any products, participate in promotional campaigns giving an impression of commercialization of medical practice.

iv. An RMP shall not give, directly or indirectly, any approval, recommendation, endorsement, certificate, report or statement concerning any drug, medicine, remedy, therapeutic article, apparatus, appliance, medical device, diagnostic product, health product or commercial product for use in advertising or publicity in connection with his/her name, signature, photograph, voice or professional status, whether or not monetary or other consideration is received.

v. Shall not publish cases for promotional purposes, advertise surgical results, display “before and after” photographs, publicize celebrity patients, promote personal success stories unless published strictly for scientific or educational purposes with anonymized patient consent.

xi. No RMP shall use or permit any celebrity, influencer, patient, employee or third party to promote professional services through prohibited testimonials, endorsements or recommendations. Any material commercial relationship in lawful public-health or informational communication shall be transparently disclosed in accordance with applicable law. No RMP or hospital/medical institution shall use a third party as an intermediary to do indirectly what the RMP or institution is prohibited from doing directly.

vi. Shall not publish any statement that creates unrealistic expectations, misrepresents treatment outcomes, conceals risks, promote unproven therapies, secret remedy or treatment whose composition, scientific basis, safety or efficacy is not adequately established or which is otherwise prohibited under applicable law.

5.2 Hoardings/Billboards in public space that are let out by concerned municipal or other authorities like state transport authority, railways, airports etc., may be used by hospitals/medical institutions and RMPs only for dissemination of factual information in the nature of infrastructure, facilities etc. Unverified or unverifiable claims shall be construed as for furtherance of commercial gains, and are prohibited.

iii. Shall not advertise either personal achievements or professional success rates or number of patients treated with illustrative assertions such as

or any other unverifiable or exaggerated claims by whatsoever name called.

iv. Medical Practitioners can issue health education and general information pamphlets/ brochures to the patients visiting their clinic/ hospital but these should not contain guarantee of cure or superiority over others or unsubstantiated claims or misleading information

d) Any use of patient information as input for an AI system shall comply with applicable privacy, confidentiality, data-protection and professional-ethics requirements.

7.6 Advertisement under these Guidelines involving processing, publication, storage, disclosure or other use of digital personal data shall comply with the provision of Information Technology Act, 2000; Digital Personal Data Protection Act, 2023 and Rules made thereunder in 2025, to the extent applicable and in force from time to time.

3.2 "Advertisement” mean any form of communication, promotion, publicity, announcement, representation or dissemination of information in any medium, which directly or indirectly solicits, promotes or is intended to promote the professional services, reputation, skills, qualifications, achievements, facilities or commercial healthcare services of an RMP or hospital/medical institution.

4.2 In relation to RMPs, these Guidelines shall be read with the IMC (Professional Conduct, Etiquette and Ethics) Regulations, 2002, as amended from time to time, and the NMC Act, 2019. In case of any irreconcilable conflict, the applicable statutory provisions and operative regulations shall prevail.